Aspirin Use Is Associated With Decreased Risk of Breast Cancer Recurrence and Death

Journal of Midwifery and Women's Health

Volumn 55, Issue 4, 2010, Pages 389-390

  Bond, Sharon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESTRADIOL; HORMONE RECEPTOR;

ABDOMINAL CRAMP; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; BACKACHE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; DISTANT METASTASIS; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG USE; ESTRADIOL BLOOD LEVEL; HEADACHE; HEALTH STATUS; HEART DISEASE; HUMAN; IMMUNE RESPONSE; MENOPAUSE; MENSTRUATION DISORDER; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; TREATMENT DURATION; TREATMENT INDICATION;

EID: 77953985980     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2010.04.002     Document Type: Review

References (2)

1. Cook N.R., Lee I.M., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., et al. Low-dose aspirin in the primary prevention of cancer: The Women's Health Study: A randomized controlled trial. JAMA 2005, 294:47-55.
2. Khuder S.A., Mutgi A.B. Breast cancer and NSAID use: A meta-analysis. Br J Cancer 2001, 84:1188-1192.